Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Impregnated Beads in Lower Extremity Osteomyelitis
NCT07072923Phase 4Not yet recruiting
- Sponsor
- University of Arizona
- Start
- Sep 2025
- Primary completion
- Jul 2027
- Modality
- Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
01
Overview
A Phase 4 trial of vancomycin, daptomycin, cefazolin, cefepime, tobramycin in osteomyelitis (OM), sponsored by University of Arizona. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
vancomycindaptomycincefazolincefepimetobramycin
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on NCT07072923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072923.